Allopathetic medicine continues to dance around magnesium deficiency conditions using more and more expensive and invasive drug therapies even though enough research has been done to show that magnesium can treat and prevent migraines that are due to magnesium deficiency.
Here is an excerpt from The Magnesium Miracle (2017):
By 2012, Dr. Mauskop had sufficient clinical success and had published enough about treating migraine with magnesium to title his paper “Why All Migraine Patients Should Be Treated with Magnesium.”[i] Dr. Mauskop enthused that “all migraine sufferers should receive a therapeutic trial of magnesium supplementation.” As he explains, “A multitude of studies have proven the presence of magnesium deficiency in migraine patients.” Double-blind, placebo-controlled trials have produced mixed results, but, as Dr. Mauskop writes, this is “most likely because both magnesium deficient and non-deficient patients were included in these trials.” Clearly, if researchers wish to show that magnesium deficiency is a cause of migraine, it’s important to test for magnesium deficiency using the Ionized Magnesium Test beforehand; otherwise, the result is a seriously flawed study.
Dr. Mauskop agrees with my statements in that we do not have a readily available reliable test to determine magnesium deficiency. He is right when he states that Serum Magnesium levels are “entirely inaccurate.” As he notes, the Magnesium RBC test is more reliable. This test is available to the public at a very reasonable cost of $49.00 from online companies such as www.requestatest.com.
Unlike other research papers that hem and haw when it comes to conclusions, Dr. Mauskop’s paper makes a declarative statement: “Considering that up to 50% of patients with migraines could potentially benefit from this extremely safe and very inexpensive treatment, it should be recommended to all migraine patients.”
The newest drug out of the gate is an injectable called Erenumab (Aimovig) for migraine prevention and the topic of a Medscape article. Erenumab is a calcitonin inhibitor. Well guess what? Calcitonin’s job is to decrease the level of calcium in the blood by suppressing parathyroid hormone. Guess what else? Magnesium does a better job of directing calcium out of the blood and into the bones and teeth where most of it belongs. Do a little more thinking and it will be obvious to you that suppressing hormones in the body is a really bad idea!
The original study that allowed the FDA to consider approval of the drug included 246 patients with refractory episodic migraine. Results showed that a 50% or greater reduction in mean monthly migraine days was achieved by 30% of those treated subcutaneously once monthly vs 13.7% of those receiving a placebo. OK, let’s do the math. If you subtract the number of people responding to placebo, ONLY 16.3% benefited with reduction in migraine. Sit back and think about that for 2.3 seconds before you scratch your head that doctors actually think this is a breakthrough drug! And the price tag is $6,900 per year!
Let me repeat Dr. Mauskop’s statement “Considering that up to 50% of patients with migraines could potentially benefit from this extremely safe and very inexpensive treatment, it should be recommended to all migraine patients.”
What makes more sense to you – using an injectable drug at a cost of $6,900 per year or … magnesium? Promoters of the drug crow that insurance will cover the cost …and we wonder why health insurance costs are doubling every couple of years!
If my words echo your experience or that of a friend, take heart and find out more about magnesium and migraines by Googling my name and migraines.
If you have received this blog from a friend, you can subscribe to my twice-weekly newsletter here: https://drcarolyndean.com/subscribe
Carolyn Dean MD ND
The Doctor of the Future®
RESOURCES: Along the borders and in the links of my web site you can find my books, writings, and my call-in radio show. Email your questions to: email@example.com.